Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sofie Peirs

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Immunological Reviews|December 17, 2014
Epigenetics in T-cell acute lymphoblastic leukemiaSofie Peirs, Joni Van der Meulen, Inge Van de Walle, et al.
Experimental Hematology|July 1, 2015
Novel biological insights in T-cell acute lymphoblastic leukemiaKaat Durinck, Steven Goossens, Sofie Peirs, et al.
Blood Advances|April 8, 2021
The spleen as a sanctuary site for residual leukemic cells following ABT-199 monotherapy in ETP-ALLAlessandra Di Grande, Sofie Peirs, Paul D Donovan, et al.
Blood|January 11, 2017
Oncogenic ZEB2 activation drives sensitivity toward KDM1A inhibition in T-cell acute lymphoblastic leukemiaSteven Goossens, Sofie Peirs, Wouter Van Loocke, et al.
Nucleic Acids Research|September 9, 2016
A quantitative proteomics approach identifies ETV6 and IKZF1 as new regulators of an ERG-driven transcriptional networkAshwin Unnikrishnan, Yi F Guan, Yizhou Huang, et al.
Blood|October 11, 2014
ABT-199 mediated inhibition of BCL-2 as a novel therapeutic strategy in T-cell acute lymphoblastic leukemiaSofie Peirs, Filip Matthijssens, Steven Goossens, et al.
Plos One|November 14, 2019
Fanconi-BRCA pathway mutations in childhood T-cell acute lymphoblastic leukemiaGayle P Pouliot, James Degar, Laura Hinze, et al.
Cancer Research|January 19, 2018
A Novel l-Asparaginase with low l-Glutaminase Coactivity Is Highly Efficacious against Both T- and B-cell Acute Lymphoblastic Leukemias <i>In Vivo</i>Hien Anh Nguyen, Ying Su, Jenny Y Zhang, et al.
The Journal of Experimental Medicine|November 9, 2018
PRC2 loss induces chemoresistance by repressing apoptosis in T cell acute lymphoblastic leukemiaIngrid M Ariës, Kimberly Bodaar, Salmaan A Karim, et al.
The Journal of Clinical Investigation|February 8, 2021
RUNX2 regulates leukemic cell metabolism and chemotaxis in high-risk T cell acute lymphoblastic leukemiaFilip Matthijssens, Nitesh D Sharma, Monique Nysus, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Immunological Reviews|December 17, 2014
Epigenetics in T-cell acute lymphoblastic leukemiaSofie Peirs, Joni Van der Meulen, Inge Van de Walle, et al.
Experimental Hematology|July 1, 2015
Novel biological insights in T-cell acute lymphoblastic leukemiaKaat Durinck, Steven Goossens, Sofie Peirs, et al.
Blood Advances|April 8, 2021
The spleen as a sanctuary site for residual leukemic cells following ABT-199 monotherapy in ETP-ALLAlessandra Di Grande, Sofie Peirs, Paul D Donovan, et al.
Blood|January 11, 2017
Oncogenic ZEB2 activation drives sensitivity toward KDM1A inhibition in T-cell acute lymphoblastic leukemiaSteven Goossens, Sofie Peirs, Wouter Van Loocke, et al.
Nucleic Acids Research|September 9, 2016
A quantitative proteomics approach identifies ETV6 and IKZF1 as new regulators of an ERG-driven transcriptional networkAshwin Unnikrishnan, Yi F Guan, Yizhou Huang, et al.
Blood|October 11, 2014
ABT-199 mediated inhibition of BCL-2 as a novel therapeutic strategy in T-cell acute lymphoblastic leukemiaSofie Peirs, Filip Matthijssens, Steven Goossens, et al.
Plos One|November 14, 2019
Fanconi-BRCA pathway mutations in childhood T-cell acute lymphoblastic leukemiaGayle P Pouliot, James Degar, Laura Hinze, et al.
Cancer Research|January 19, 2018
A Novel l-Asparaginase with low l-Glutaminase Coactivity Is Highly Efficacious against Both T- and B-cell Acute Lymphoblastic Leukemias <i>In Vivo</i>Hien Anh Nguyen, Ying Su, Jenny Y Zhang, et al.
The Journal of Experimental Medicine|November 9, 2018
PRC2 loss induces chemoresistance by repressing apoptosis in T cell acute lymphoblastic leukemiaIngrid M Ariës, Kimberly Bodaar, Salmaan A Karim, et al.
The Journal of Clinical Investigation|February 8, 2021
RUNX2 regulates leukemic cell metabolism and chemotaxis in high-risk T cell acute lymphoblastic leukemiaFilip Matthijssens, Nitesh D Sharma, Monique Nysus, et al.
Pageof 2